nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—OPRM1—autistic disorder	0.734	1	CbGaD
Buprenorphine—OPRM1—telencephalic ventricle—autistic disorder	0.00728	0.0837	CbGeAlD
Buprenorphine—OPRL1—brainstem—autistic disorder	0.00561	0.0645	CbGeAlD
Buprenorphine—OPRL1—forebrain—autistic disorder	0.00541	0.0622	CbGeAlD
Buprenorphine—OPRL1—telencephalon—autistic disorder	0.00498	0.0572	CbGeAlD
Buprenorphine—OPRL1—head—autistic disorder	0.0031	0.0356	CbGeAlD
Buprenorphine—OPRL1—nervous system—autistic disorder	0.00294	0.0338	CbGeAlD
Buprenorphine—OPRL1—central nervous system—autistic disorder	0.00283	0.0325	CbGeAlD
Buprenorphine—OPRD1—forebrain—autistic disorder	0.00279	0.032	CbGeAlD
Buprenorphine—OPRK1—forebrain—autistic disorder	0.00267	0.0307	CbGeAlD
Buprenorphine—OPRD1—telencephalon—autistic disorder	0.00256	0.0295	CbGeAlD
Buprenorphine—UGT1A9—digestive system—autistic disorder	0.00248	0.0285	CbGeAlD
Buprenorphine—OPRL1—brain—autistic disorder	0.00225	0.0258	CbGeAlD
Buprenorphine—CYP2C18—digestive system—autistic disorder	0.00216	0.0249	CbGeAlD
Buprenorphine—Methylnaltrexone—OPRM1—autistic disorder	0.00197	0.202	CrCbGaD
Buprenorphine—Butorphanol—OPRM1—autistic disorder	0.00197	0.202	CrCbGaD
Buprenorphine—OPRM1—brainstem—autistic disorder	0.00197	0.0226	CbGeAlD
Buprenorphine—OPRM1—forebrain—autistic disorder	0.0019	0.0219	CbGeAlD
Buprenorphine—Nalbuphine—OPRM1—autistic disorder	0.00181	0.185	CrCbGaD
Buprenorphine—OPRM1—telencephalon—autistic disorder	0.00175	0.0201	CbGeAlD
Buprenorphine—OPRD1—head—autistic disorder	0.0016	0.0183	CbGeAlD
Buprenorphine—OPRK1—head—autistic disorder	0.00153	0.0176	CbGeAlD
Buprenorphine—OPRD1—nervous system—autistic disorder	0.00151	0.0174	CbGeAlD
Buprenorphine—Naltrexone—OPRM1—autistic disorder	0.00147	0.151	CrCbGaD
Buprenorphine—Oxymorphone—OPRM1—autistic disorder	0.00147	0.151	CrCbGaD
Buprenorphine—OPRD1—central nervous system—autistic disorder	0.00146	0.0167	CbGeAlD
Buprenorphine—OPRK1—nervous system—autistic disorder	0.00145	0.0167	CbGeAlD
Buprenorphine—OPRK1—central nervous system—autistic disorder	0.0014	0.0161	CbGeAlD
Buprenorphine—CYP2D6—hindbrain—autistic disorder	0.00138	0.0158	CbGeAlD
Buprenorphine—OPRK1—cerebellum—autistic disorder	0.00137	0.0157	CbGeAlD
Buprenorphine—OPRD1—brain—autistic disorder	0.00116	0.0133	CbGeAlD
Buprenorphine—OPRK1—brain—autistic disorder	0.00111	0.0127	CbGeAlD
Buprenorphine—OPRM1—head—autistic disorder	0.00109	0.0125	CbGeAlD
Buprenorphine—Naloxone—OPRM1—autistic disorder	0.00107	0.11	CrCbGaD
Buprenorphine—CYP2A6—cerebellum—autistic disorder	0.00104	0.012	CbGeAlD
Buprenorphine—OPRM1—nervous system—autistic disorder	0.00103	0.0119	CbGeAlD
Buprenorphine—ABCG2—telencephalon—autistic disorder	0.00102	0.0118	CbGeAlD
Buprenorphine—OPRM1—central nervous system—autistic disorder	0.000994	0.0114	CbGeAlD
Buprenorphine—CYP2C19—digestive system—autistic disorder	0.00092	0.0106	CbGeAlD
Buprenorphine—CYP2A6—brain—autistic disorder	0.000846	0.00972	CbGeAlD
Buprenorphine—CYP2D6—brainstem—autistic disorder	0.00079	0.00908	CbGeAlD
Buprenorphine—OPRM1—brain—autistic disorder	0.000789	0.00907	CbGeAlD
Buprenorphine—CYP2D6—forebrain—autistic disorder	0.000762	0.00876	CbGeAlD
Buprenorphine—CYP1A2—digestive system—autistic disorder	0.000751	0.00863	CbGeAlD
Buprenorphine—CYP3A5—digestive system—autistic disorder	0.000725	0.00833	CbGeAlD
Buprenorphine—CYP2C9—digestive system—autistic disorder	0.000713	0.0082	CbGeAlD
Buprenorphine—CYP2D6—telencephalon—autistic disorder	0.000701	0.00806	CbGeAlD
Buprenorphine—ABCG2—cerebellum—autistic disorder	0.000568	0.00653	CbGeAlD
Buprenorphine—ABCB1—forebrain—autistic disorder	0.000548	0.0063	CbGeAlD
Buprenorphine—CYP3A4—digestive system—autistic disorder	0.000544	0.00625	CbGeAlD
Buprenorphine—CYP2D6—digestive system—autistic disorder	0.000535	0.00615	CbGeAlD
Buprenorphine—ABCB1—telencephalon—autistic disorder	0.000504	0.0058	CbGeAlD
Buprenorphine—CYP2C8—brain—autistic disorder	0.000475	0.00545	CbGeAlD
Buprenorphine—ABCG2—brain—autistic disorder	0.000462	0.0053	CbGeAlD
Buprenorphine—CYP2D6—head—autistic disorder	0.000437	0.00502	CbGeAlD
Buprenorphine—CYP3A4—nervous system—autistic disorder	0.000421	0.00483	CbGeAlD
Buprenorphine—CYP2D6—nervous system—autistic disorder	0.000414	0.00476	CbGeAlD
Buprenorphine—CYP3A4—central nervous system—autistic disorder	0.000405	0.00465	CbGeAlD
Buprenorphine—CYP2D6—central nervous system—autistic disorder	0.000399	0.00458	CbGeAlD
Buprenorphine—CYP2D6—cerebellum—autistic disorder	0.00039	0.00448	CbGeAlD
Buprenorphine—ABCB1—digestive system—autistic disorder	0.000385	0.00442	CbGeAlD
Buprenorphine—CYP2D6—brain—autistic disorder	0.000316	0.00364	CbGeAlD
Buprenorphine—ABCB1—head—autistic disorder	0.000314	0.00361	CbGeAlD
Buprenorphine—ABCB1—nervous system—autistic disorder	0.000298	0.00342	CbGeAlD
Buprenorphine—ABCB1—central nervous system—autistic disorder	0.000287	0.00329	CbGeAlD
Buprenorphine—ABCB1—cerebellum—autistic disorder	0.00028	0.00322	CbGeAlD
Buprenorphine—ABCB1—brain—autistic disorder	0.000228	0.00262	CbGeAlD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	1.4e-05	8.31e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PIK3CG—autistic disorder	1.4e-05	8.28e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—APC—autistic disorder	1.4e-05	8.28e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PLA2G4A—autistic disorder	1.4e-05	8.26e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CAT—autistic disorder	1.39e-05	8.25e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—DPYD—autistic disorder	1.39e-05	8.23e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TSC2—autistic disorder	1.39e-05	8.22e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GPX1—autistic disorder	1.39e-05	8.21e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SLC19A1—autistic disorder	1.39e-05	8.21e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EGF—autistic disorder	1.38e-05	8.18e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GPX1—autistic disorder	1.38e-05	8.14e-05	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2—autistic disorder	1.36e-05	8.05e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—APOE—autistic disorder	1.36e-05	8.04e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—LEP—autistic disorder	1.36e-05	8.04e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MEF2C—autistic disorder	1.36e-05	8.04e-05	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL6—autistic disorder	1.36e-05	8.02e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.35e-05	8e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—DHFR—autistic disorder	1.35e-05	7.99e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	1.34e-05	7.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.34e-05	7.92e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—TPH2—autistic disorder	1.33e-05	7.88e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—POMC—autistic disorder	1.33e-05	7.88e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CACNA1C—autistic disorder	1.32e-05	7.84e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ITGB3—autistic disorder	1.32e-05	7.83e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—TPH2—autistic disorder	1.32e-05	7.81e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTM1—autistic disorder	1.32e-05	7.79e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PLA2G4A—autistic disorder	1.32e-05	7.79e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—DPYD—autistic disorder	1.31e-05	7.75e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—DPYD—autistic disorder	1.3e-05	7.69e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—RORA—autistic disorder	1.3e-05	7.66e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CACNA1C—autistic disorder	1.29e-05	7.65e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PRKCB—autistic disorder	1.28e-05	7.58e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IGF1—autistic disorder	1.28e-05	7.58e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MTHFR—autistic disorder	1.28e-05	7.58e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—MAPK1—autistic disorder	1.27e-05	7.54e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.27e-05	7.54e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MTHFR—autistic disorder	1.27e-05	7.51e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PIK3CG—autistic disorder	1.27e-05	7.5e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GPX1—autistic disorder	1.26e-05	7.46e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADSL—autistic disorder	1.24e-05	7.31e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR2A—autistic disorder	1.24e-05	7.31e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2—autistic disorder	1.23e-05	7.31e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—APC—autistic disorder	1.23e-05	7.26e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PIK3CG—autistic disorder	1.23e-05	7.26e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP19A1—autistic disorder	1.22e-05	7.22e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.22e-05	7.22e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CACNA1C—autistic disorder	1.22e-05	7.21e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—autistic disorder	1.22e-05	7.2e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SERPINE1—autistic disorder	1.22e-05	7.2e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MAOB—autistic disorder	1.21e-05	7.18e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EGF—autistic disorder	1.21e-05	7.17e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—XDH—autistic disorder	1.21e-05	7.17e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CACNA1C—autistic disorder	1.21e-05	7.15e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—POMC—autistic disorder	1.21e-05	7.14e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—DHFR—autistic disorder	1.2e-05	7.13e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—APOE—autistic disorder	1.19e-05	7.05e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—STX1A—autistic disorder	1.19e-05	7.04e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NPAS2—autistic disorder	1.19e-05	7.04e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—APOE—autistic disorder	1.18e-05	6.99e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—DHFR—autistic disorder	1.18e-05	6.96e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TSC2—autistic disorder	1.17e-05	6.94e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—POMC—autistic disorder	1.17e-05	6.91e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MTHFR—autistic disorder	1.16e-05	6.88e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.16e-05	6.87e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.16e-05	6.83e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—TCN2—autistic disorder	1.15e-05	6.8e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APOE—autistic disorder	1.15e-05	6.8e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—LEP—autistic disorder	1.15e-05	6.8e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.14e-05	6.73e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—COMT—autistic disorder	1.13e-05	6.71e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTP1—autistic disorder	1.13e-05	6.68e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—TPH2—autistic disorder	1.13e-05	6.68e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MAOA—autistic disorder	1.13e-05	6.67e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IGF1—autistic disorder	1.12e-05	6.64e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—MAPK1—autistic disorder	1.12e-05	6.61e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—DPYD—autistic disorder	1.11e-05	6.57e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—DHFR—autistic disorder	1.11e-05	6.56e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CAT—autistic disorder	1.1e-05	6.5e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—DHFR—autistic disorder	1.1e-05	6.5e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADA—autistic disorder	1.1e-05	6.49e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PRKCB—autistic disorder	1.08e-05	6.41e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—APOE—autistic disorder	1.08e-05	6.41e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PIK3CG—autistic disorder	1.08e-05	6.36e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SERPINE1—autistic disorder	1.07e-05	6.31e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PIK3CG—autistic disorder	1.07e-05	6.31e-05	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTEN—autistic disorder	1.06e-05	6.28e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP19A1—autistic disorder	1.06e-05	6.26e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.04e-05	6.17e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTM1—autistic disorder	1.04e-05	6.14e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PLA2G4A—autistic disorder	1.04e-05	6.14e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PIK3CG—autistic disorder	1.04e-05	6.13e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—APC—autistic disorder	1.04e-05	6.13e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CACNA1C—autistic disorder	1.03e-05	6.11e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EGF—autistic disorder	1.02e-05	6.06e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—POMC—autistic disorder	1.02e-05	6.06e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HRAS—autistic disorder	1.02e-05	6.05e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.02e-05	6.01e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—POMC—autistic disorder	1.01e-05	6e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—RORA—autistic disorder	1e-05	5.91e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GPX1—autistic disorder	9.94e-06	5.88e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	9.92e-06	5.87e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	9.92e-06	5.87e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—POMC—autistic disorder	9.87e-06	5.84e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2—autistic disorder	9.84e-06	5.82e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—COMT—autistic disorder	9.83e-06	5.82e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL6—autistic disorder	9.79e-06	5.79e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTP1—autistic disorder	9.78e-06	5.79e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PIK3CG—autistic disorder	9.77e-06	5.78e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MAOA—autistic disorder	9.76e-06	5.77e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—autistic disorder	9.63e-06	5.7e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CAT—autistic disorder	9.52e-06	5.63e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IGF1—autistic disorder	9.49e-06	5.62e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—MAPK1—autistic disorder	9.45e-06	5.59e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP19A1—autistic disorder	9.44e-06	5.58e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—DHFR—autistic disorder	9.39e-06	5.56e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MAOB—autistic disorder	9.37e-06	5.54e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—POMC—autistic disorder	9.3e-06	5.5e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	9.26e-06	5.48e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PTEN—autistic disorder	9.26e-06	5.48e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP19A1—autistic disorder	9.21e-06	5.45e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MTHFR—autistic disorder	9.17e-06	5.43e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SERPINE1—autistic disorder	9.01e-06	5.33e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PLA2G4A—autistic disorder	8.99e-06	5.32e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTM1—autistic disorder	8.99e-06	5.32e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HRAS—autistic disorder	8.97e-06	5.31e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	8.86e-06	5.24e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—COMT—autistic disorder	8.77e-06	5.19e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTP1—autistic disorder	8.73e-06	5.17e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MAOA—autistic disorder	8.71e-06	5.15e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—TPH2—autistic disorder	8.71e-06	5.15e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP19A1—autistic disorder	8.68e-06	5.14e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2—autistic disorder	8.63e-06	5.11e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GPX1—autistic disorder	8.61e-06	5.09e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP19A1—autistic disorder	8.61e-06	5.09e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL6—autistic disorder	8.59e-06	5.08e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—DPYD—autistic disorder	8.57e-06	5.07e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—COMT—autistic disorder	8.56e-06	5.07e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—APOE—autistic disorder	8.54e-06	5.05e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTP1—autistic disorder	8.52e-06	5.04e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MAOA—autistic disorder	8.5e-06	5.03e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CAT—autistic disorder	8.5e-06	5.03e-05	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTEN—autistic disorder	8.39e-06	4.97e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CAT—autistic disorder	8.29e-06	4.91e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—autistic disorder	8.17e-06	4.83e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PTEN—autistic disorder	8.12e-06	4.81e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—autistic disorder	8.1e-06	4.79e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	8.08e-06	4.78e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—COMT—autistic disorder	8.07e-06	4.77e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTP1—autistic disorder	8.03e-06	4.75e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PLA2G4A—autistic disorder	8.02e-06	4.75e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTM1—autistic disorder	8.02e-06	4.75e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MAOA—autistic disorder	8.01e-06	4.74e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—COMT—autistic disorder	8e-06	4.73e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CACNA1C—autistic disorder	7.96e-06	4.71e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTP1—autistic disorder	7.96e-06	4.71e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTHFR—autistic disorder	7.95e-06	4.7e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MAOA—autistic disorder	7.94e-06	4.7e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	7.91e-06	4.68e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PLA2G4A—autistic disorder	7.83e-06	4.63e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTM1—autistic disorder	7.83e-06	4.63e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CAT—autistic disorder	7.82e-06	4.62e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CAT—autistic disorder	7.75e-06	4.58e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PIK3CG—autistic disorder	7.71e-06	4.56e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GPX1—autistic disorder	7.68e-06	4.55e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HRAS—autistic disorder	7.58e-06	4.49e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MAPK1—autistic disorder	7.53e-06	4.46e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GPX1—autistic disorder	7.5e-06	4.44e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—autistic disorder	7.42e-06	4.39e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—APOE—autistic disorder	7.4e-06	4.38e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PLA2G4A—autistic disorder	7.38e-06	4.37e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTM1—autistic disorder	7.38e-06	4.37e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP19A1—autistic disorder	7.35e-06	4.35e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—POMC—autistic disorder	7.34e-06	4.34e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PLA2G4A—autistic disorder	7.32e-06	4.33e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTM1—autistic disorder	7.32e-06	4.33e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2—autistic disorder	7.29e-06	4.32e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL6—autistic disorder	7.26e-06	4.29e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—DHFR—autistic disorder	7.25e-06	4.29e-05	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTEN—autistic disorder	7.12e-06	4.21e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTHFR—autistic disorder	7.09e-06	4.2e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GPX1—autistic disorder	7.07e-06	4.18e-05	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTEN—autistic disorder	7.06e-06	4.18e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GPX1—autistic disorder	7.01e-06	4.15e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTHFR—autistic disorder	6.92e-06	4.1e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	6.9e-06	4.08e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTEN—autistic disorder	6.86e-06	4.06e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—COMT—autistic disorder	6.84e-06	4.04e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTP1—autistic disorder	6.8e-06	4.03e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MAOA—autistic disorder	6.79e-06	4.02e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PIK3CG—autistic disorder	6.68e-06	3.95e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CAT—autistic disorder	6.62e-06	3.92e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MAPK1—autistic disorder	6.6e-06	3.91e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—APOE—autistic disorder	6.6e-06	3.91e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTHFR—autistic disorder	6.52e-06	3.86e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTEN—autistic disorder	6.47e-06	3.83e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTHFR—autistic disorder	6.47e-06	3.83e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—APOE—autistic disorder	6.44e-06	3.81e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—POMC—autistic disorder	6.35e-06	3.76e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PLA2G4A—autistic disorder	6.25e-06	3.7e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTM1—autistic disorder	6.25e-06	3.7e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—APOE—autistic disorder	6.07e-06	3.59e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HRAS—autistic disorder	6.04e-06	3.58e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—APOE—autistic disorder	6.02e-06	3.56e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GPX1—autistic disorder	5.99e-06	3.54e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PIK3CG—autistic disorder	5.96e-06	3.53e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—autistic disorder	5.85e-06	3.46e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PIK3CG—autistic disorder	5.82e-06	3.44e-05	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL6—autistic disorder	5.79e-06	3.42e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP19A1—autistic disorder	5.68e-06	3.36e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—POMC—autistic disorder	5.67e-06	3.36e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MAPK1—autistic disorder	5.58e-06	3.3e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—POMC—autistic disorder	5.54e-06	3.28e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTHFR—autistic disorder	5.53e-06	3.27e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PIK3CG—autistic disorder	5.48e-06	3.24e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PIK3CG—autistic disorder	5.43e-06	3.21e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HRAS—autistic disorder	5.3e-06	3.14e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—COMT—autistic disorder	5.28e-06	3.12e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTP1—autistic disorder	5.25e-06	3.11e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MAOA—autistic disorder	5.24e-06	3.1e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—POMC—autistic disorder	5.22e-06	3.09e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—POMC—autistic disorder	5.17e-06	3.06e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—APOE—autistic disorder	5.14e-06	3.04e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CAT—autistic disorder	5.11e-06	3.02e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTEN—autistic disorder	5.1e-06	3.02e-05	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL6—autistic disorder	5.07e-06	3e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—autistic disorder	5.07e-06	3e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PLA2G4A—autistic disorder	4.83e-06	2.86e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTM1—autistic disorder	4.83e-06	2.86e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PIK3CG—autistic disorder	4.64e-06	2.75e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GPX1—autistic disorder	4.62e-06	2.73e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—autistic disorder	4.52e-06	2.68e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HRAS—autistic disorder	4.48e-06	2.65e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTEN—autistic disorder	4.42e-06	2.62e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—POMC—autistic disorder	4.42e-06	2.61e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—autistic disorder	4.42e-06	2.61e-05	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL6—autistic disorder	4.29e-06	2.54e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTHFR—autistic disorder	4.26e-06	2.52e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—autistic disorder	4.16e-06	2.46e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—autistic disorder	4.12e-06	2.44e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—APOE—autistic disorder	3.97e-06	2.35e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTEN—autistic disorder	3.95e-06	2.33e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTEN—autistic disorder	3.85e-06	2.28e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTEN—autistic disorder	3.63e-06	2.15e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTEN—autistic disorder	3.6e-06	2.13e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PIK3CG—autistic disorder	3.58e-06	2.12e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—autistic disorder	3.52e-06	2.09e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—POMC—autistic disorder	3.41e-06	2.02e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTEN—autistic disorder	3.07e-06	1.82e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—autistic disorder	2.72e-06	1.61e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTEN—autistic disorder	2.37e-06	1.4e-05	CbGpPWpGaD
